¤@¡³¤G¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- §K¬Ì¬ì

(B) 1. ¤U¦C¦³Ãö¹L±Ó©Ê»óª¢ªº´y­z¡A¦óªÌ³Ì¬°¥¿½T¡H
A.©u¸`«¬ªº±wªÌ»PÅðµß(mold)¹L±Ó­ì³Ì¦³Ãö«Y
B.¸g¦~«¬ªº±wªÌ»P¹Ðúu(house dust mite)¹L±Ó­ì³Ì¦³Ãö«Y
C.©â¦åÀˬd¹L±Ó­ìªº¯S²§©Ê§ÜÅé³Ì¨ã¶EÂ_¯S²§©Ê
D.©u¸`«¬ªº±wªÌ¦å²M¤¤ªºIgE³q±`¤£·|°ª
E.¤Þ°_¹L±Ó©Ê»óª¢ªº¹L±Ó­ì²É¤l³q±`¤ñ®ð³Ý¹L±Ó­ì¬°¤p
 
(E) 2. 24·³ªº¤k©Ê±wªÌ¿©±wëC³Â¯l¼Ëªº¥Ö½§·kÄo¦³¤@¦~¥|­Ó¤ë¤§¤[¡A¨C¦¸µo§@®É¥Ö½§·|¿±°_¡A¸g¥|¤Ñ¤§«á¤~·|®ø¥¢¡C¥Ö½§¤Á¤ùÀˬdµo²{¤pÀR¯ß¦³µoª¢²Ó­Mªº®û¼í¤Îfibrinoid necrosis¡C½Ð°Ýªø´Á¨Ï¥Î¤U¦C¦óªÌÃĪ«³Ì¬°¾A·í¡H
A.H1 anti-histamine
B.Local application of corticosteroid ointment
C.Methotrexate
D.Anti-IgE therapy
E.Hydroxychloroquine
 
(A) 3. 27·³¨k©Ê±wªÌªñ¥b¦~¨Ó¦³­«½Æ©Êªº¤fµÄ¤Î¦ÞÀYÂH½¤ªº¯kµh©Ê¼ìºÅ¡C¨Ã¥B·|¦³¦h³BÃö¸`»Äµh¡A¨ä¶¡°¸¦Ó¤UªÏ·|¥X²{À£µh©Êªº¬õ´³¡C¦¹¬õ´³¯fÅÜ´¿³QÂå®vÃhºÃ¬°¦åºÞª¢¡C¤S¡A±wªÌ¬°ºC©ÊB¨x±a­ìªÌ¡A©â¦åÀˬdµo²{ANA 1:160 speckled pattern¡Brheumatoid factor(RF) 108 IU/ml (normal < 10 IU/ml)¡BC3¤ÎC4¥¿±`¡B HLA-B27 (+)¡C½Ð°Ý³Ì¦³¥i¯àªº¶EÂ_¬°¦ó¡H
A.Behcet's disease
B.SLE
C. Rheumatoid arthratis (RA)
D.Leukocytoclastic vasculitis
E.Chronic urticaria
 
(D) 4. 28·³ªº¤k©ÊSLE±wªÌ¦³¤T¦¸¬y²£¤Î¤@¦¸¦º²£¤§Ãh¥¥¥v¡C½Ð°Ý¤U¦Cªº¦óºØ§ÜÅé»P²ßºD©Ê¬y²£³Ì¦³¬ÛÃö¡H
A.Anti-dsDNA
B.Anti-SSB/La
C.Anti-Sm/anti-RNP
D.Anti-£]2GPI
E.Anti-PCNA
 
(C) 5. ¤@¦ì¿©±w¯T½HµÇª¢ªº±wªÌ¨C¤é§ë¤©prednisolone 10mg¤Îazathioprine 100mg¡C¦³¤@¤Ñ¨äserum creatinine¥Ñ­ì¥»ªº1.8mg/dL¦b¤G­Ó¤ë¤§¤º§Ö³t¤Wª@¦Ü5.3mg/dL¡A¦Ó¥B¦³¤UªÏ¯B¸~¥X²{¡C½Ð°ÝÀ³¸Ó°¨¤Wµ¹¤©¦óºØÃĪ«ªvÀø³Ì¬°«ê·í¡H
A.Methylprednisolone pulse therapy
B.Oral mycophenolate mofetil
C.Cyclophosphamide pulse therapy
D.Rituximab IV infusion
E.Belimumab IV infusion
 
(B) 6. ¤@¦ì31·³ªº¤k©Ê¦b¤G¤Ñ«e¥k¤U»L¬ðµMµo¥Í¸~µÈ¼@µh¡C¸g©â¦åÀˬdµo²{ESR 41 mm/h¡BCRP 2.3mg/dL¡BANA 1:80 speckled pattern, blood culture (-)¡BPT¥¿±`¡A¦ýPTT©µªø¦Ü53¬í¡]¥¿±`36¬í¡^¡BAnti-SSA 34.6 AU/mL (normal < 1.2)¡Aanti-SSB < 1.2 AU/ml¡BDRVVT¤W¤É¡C½Ð°Ý¤U¦C¦óºØÃĪ«ªº¤Î®ÉªvÀø³Ì¬°«ê·í¡H
A.Intravenous antibiotics
B.Low molecular weight heparin infusion
C.Corticosteroid 1mg/kg/day IV infusion
D.Oral cylophosphamide 100mg/day
E.Intravenous immunoglobulin for 5 days
 
(D) 7. 58·³ªº¤k©Ê±wªÌ¥D¶D¬°Raynaud's phenomenon¦³¤@¦~¤§¤[¡Cªñ¤T­Ó¤ë¨Ó¨â¤â­Iªº¥Ö½§³vº¥Åܵw¡C¥t¥~¡A¦YªF¦è®e©ö¶æ¨ì¡CÂå®vÃhºÃ¦o¿©±wµw¥Ö¯g¡C§K¬Ì¾ÇÀˬdµo²{anti-Scl-70¬° 126 AU/mL (normal<1.5 AU/mL)¡AªÍ¥\¯à¤Îdiffusion capacity of carbon monoxide(DLCO)Àˬd¥¿±`¡C½Ð°Ý¤U¦C¦óªÌ¬°­º¿ïÃĪ«?
A.Cyclophosphamide pulse therapy
B.High dose oral corticosteroids
C.Colchicine
D.D-penicillamine
E.Methotrexate
 
(E) 8. ¦³Ãö»øª½©Ê¯á´Õª¢ªº¦å²G¤Î¦å²M¾ÇÀˬd¼Æ¾Ú¦p¤U¡A½Ð°Ý¦óªÌ³Ì¬°¥¿½T?(1) ANA(+) (2) ESR¤W¤É( 3) CRP¤W¤É (4) RF (+) (5)Anti-CCP (-) (6) HLA-B27(+) (7) ANCA(+)
A.(1)+(2)+(3)
B.(4)+(5)+(6)
C.(2)+(4)+(7)
D.(3)+(4)+(5)
E.(3)+(5)+(6)
 
(A) 9. ¤U¦C¦³Ãö¦UºØvasculitis syndromesªº¯e¯f¯S¼xªº´y­z¡A¦óªÌ³Ì¬°¥¿½T¡H(1)Granulomatosis with polyangiitis--cANCA (+) (2) Henoch-Schonlein purpura--serum IgE¤W¤É (3)Polyarteritis nodosa-paranasal sinusitis (4)Takayasu's arteritis--pulseless disease (5)Leukocytoclastic vasculitis--pANCA (+) (6)Churg-Strauss syndrome--allergic manifestations (7)Temporal arteritis--serum IgA¤W¤É
A.(1)+(4)+(6)
B.(1)+(2)+(3)
C.(3)+(4)+(5)
D.(2)+(6)+(7)
E.(3)+(5)+(7)
 
(B) 10. ¤U¦C¦³Ãö¦UºØÃö¸`ª¢ªº¯e¯f¯S¼x´y­z¡A¦óºØ²Õ¦X³Ì¬°¥¿½T¡H (1) Osteoarthritis--osteophyte formation (2) Rheumatoid arthritis--marginal bone erosion (3) Psoriatic arthropathy--osteonecrosis (4) Pseudogout--monosodium urate deposit (5) Ankylosing spondylitis--chronic synovitis (6) Frozen shoulder--tendinitis (7) Reactive arthritis--enthesitis
A.(1)+(3)+(5)
B.(2)+(6)+(7)
C.(3)+(4)+(5)
D.(1)+(4)+(7)
E.(2)+(5)+(6)
 


< ¤@¡³¤G¦~«×¸ÕÃD¥Ø¿ý >